Microbial Stool Biomarkers for Prediction of Autism and ADHD in Children

Status: Unknown
Location: See location...
Study Type: Observational
SUMMARY

Autism (ASD) is one of the frequent neurodevelopmental disorders that children would occur. Many studies have shown that individuals with Autism are more common to experience significant gastrointestinal problems than other individuals. Symptoms include constipation, diarrhea, abdominal pain and gastric reflux. A recent study with 50 children with ASD, 50 children with other developmental disabilities and 50 healthy control children, it found that 70% of ASD children had presented with GI symptoms, compared with 42% of developmental disabilities children and 28% of developing children, it is believed that ASD children will have a distinctive microbial pattern in the stool. Attention-deficit/hyperactivity disorder (ADHD) is another neurodevelopmental and neurobehavioral disorder. A study found that ADHD individuals experience significantly higher rate of stomach pain and bowel problems than other control individuals. It is suggested that the microbiota in the stool of ADHD children might be different. Genetic study also found that if a child has a sibling with ADHD, the risk of developing ADHD is three to four times higher than that of children with siblings without ADHD.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:

⁃ Case group, Sibling group and Control group:

• Children aged under 18 years old; and

• The parents or legal guardian agree to hand in the stool samples of children; and agree to complete questionnaires; and

• The parents or legal guardian agree to sign the informed consent form for the children

⁃ Parent group:

• Their suspected or confirmed ASD or ADHD children participated in the study; and

• Agree to hand in stool samples and complete questionnaires; and

• Agree to sign the informed consent consent

Locations
Other Locations
Hong Kong Special Administrative Region
Prince of Wales Hospital
RECRUITING
Hong Kong
Contact Information
Primary
Terence Yeung, Bsc
wanchunyeung@cuhk.edu.hk
26373225
Backup
Long Ip, Bsc
longip@cuhk.edu.hk
26373225
Time Frame
Start Date: 2021-05-15
Completion Date: 2024-12-31
Participants
Target number of participants: 320
Treatments
ASD and/or ADHD children (Case group)
Suspected or confirmed cases of ASD and/or ADHD children (Case group); no intervention(s) to be administered.
Parent group
Parents of suspected or confirmed cases of ASD and/or ADHD children; no intervention(s) to be administered.
Sibling group
Typically developed siblings of suspected or confirmed cases of ASD and/or ADHD children; no intervention(s) to be administered.
Control group
Typically developed children not related to the case group ; no intervention(s) to be administered.
Sponsors
Leads: Chinese University of Hong Kong

This content was sourced from clinicaltrials.gov